ReviewReviews in the neurosciences2026
Prognostic factors in prolonged disorders of consciousness: a narrative review.
Review in Reviews in the neurosciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Elucidating the factors that influence the recovery of impaired consciousness in patients with prolonged disorders of consciousness (pDoC) is essential for guiding neurorehabilitation strategies and improving prognostic accuracy. This review synthesizes evidence from multiple studies that investigated prognostic factors in pDoC using various approaches, including clinical and demographic characteristics, biomarkers, behavioral assessments, pharmacological treatments, neuromodulation techniques, neuroimaging, and electroencephalography. Results indicate that several indicators show significant correlations with functional outcomes at follow-up intervals ranging from 2 months to several years. These findings assist in selecting appropriate assessment tools and support clinical decision-making for pDoC patients. However, limitations such as small sample sizes, absence of control groups, and heterogeneity in follow-up durations were noted across studies. The development of large-scale, multimodal prognostic models is warranted to enhance clinical applicability and predictive power.
Indexed as
Identifiers
41021865What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.